CME Credits: 0.25
NASH: Advances in non-invasive screening
An overview of the latest in non-invasive screening for NASH, produced in association with Hepatology Knowledge into Practice
Chief of the Division of Endocrinology, Diabetes & Metabolism, The University of Florida, USA
Dr. Cusi is a Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at The University of Florida at Gainesville, and at the Veterans Administration Medical Center at Gainesville, FL (2011-present). He completed his early medical training in Buenos Aires, Argentina, and fellowship in endocrinology at Baylor College of Medicine, Houston, Texas. His earlier career was at the University of San Antonio Health Science Center, Texas (1992-2011) was on the role of defects in insulin secretion and of insulin resistance in the development of T2DM. He later focused on the role of nonalcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH), a common complication in diabetes needing the same awareness as retinopathy, nephropathy or cardiovascular disease. Dr. Cusi has published more than 200 peer-reviewed manuscripts in the fields of obesity, type 2 diabetes and NAFLD. He has contributed to several guidelines in NAFLD. His basic and clinical research programs at the University of Florida include funding from the National Institute of Health and from industry, with a focus on the mechanisms leading to NASH and search for new treatments. He received from The University of Florida the prestigious Exemplary Teacher Award, as well as the Clinical Research Award for Outstanding Achievement, Research Discovery, and Productivity. In 2020, he received the American Association of Clinical Endocrinologists (AACE) Jack Baskin, MD, Endocrine Teaching Award.
An overview of the latest in non-invasive screening for NASH, produced in association with Hepatology Knowledge into Practice
In this podcast series, we look into the importance of considering the potential presence of NASH during type 2 diabetes management